MAPS speaks with José Borbolla, Global Executive Medical Director at Esai, and Augusto Grinspan, VP Medical Affairs and Head LATAM with Merck KGaA about the evolution of Medical Affairs in Latin America.
This webinar analyzes the current state of Medical Affairs in Japan, highlights progress made and provides suggestions on what we can do together to make Medical Affairs in Japan even more effective.
MAPS speaks with Tim Mikhelashvili, PharmD, CEO & Co-Founder, Amedea Pharma, Inc. and Riaz Abbas, Learning and Performance Lead, JAPAC Medical, Amgen about innovative approaches to Medical Affairs External Education.
In this interview recorded at MAPS 2022 Global with Marija Geertsen, MD, MBA, we discuss the role of Medical Affairs in engaging with patients and patient communities.
In this interview recorded at MAPS 2022 Global with Monica de Abadal, SVP, Head North America Medical Affairs, Ipsen, we discuss how Medical Affairs benefits patients and society.
This podcast, recorded at the MAPS 2022 Global Annual Meeting, addresses the unique position of Medical Affairs in the rare disease space & how our work in this area is essential for patient benefit.
Medical technologies require equipping health care providers with the theoretical knowledge of best and safest use and also ensuring users’ practical competence. This article by the MAPS MedTech and External Education FAWGs overviews these best practices.
Charlotte Kremer (former Astellas) speaks with Danie du Plessis (Kyowa Kirin) and Bjorn Oddens (Merck) about whether Medical Affairs is truly the third strategic pillar.
How do leaders make their way to Medical Safety & Pharmacovigilance? The routes are diverse but one constant remains true: They are extremely committed to being an independent voice that amplifies their organization’s commitment to Patient Centricity.
Digitalization offers Medical Affairs teams the opportunity to rethink strategy and actions across the lifecycle of traditional and nontraditional products.